Abstract:Background: ApoA-IV is associated with HDL in plasma but a large portion circulates lipid free. It has been shown to possess anti-inflammatory and anti-atherosclerotic effects. Methods and Results: We isolated HDL from plasma of type 2 diabetic patients and healthy controls, and found that apoA-IV of HDL from diabetic patients was significantly glycated by using Western blot and mass spectrometry. The glycation levels of apoA-IV were higher in diabetic patients than in controls, and were associated with the severity of coronary artery disease. Immunohistochemically, glycation sites co-localized with apoA-IV in atherosclerotic plaques from diabetic patients. In cell and animal studies, in vitro glycated apoA-IV protein promoted inflammatory reactions in human aortic endothelial cells and atherogenesis in apoE-KO mice as compared with control, whereas apoA-IV exhibited anti-inflammatory and anti-atherogenic effects. The pro-inflammatory action of glycated apoA-IV was mediated by receptor for glycation end products in endothelial cells. In microarray analysis and verification in endothelial cells, glycated apoA-IV but not apoA-IV, enhanced the expression of nuclear receptor NR4A3 greatly. Glycated apoA-IV-induced inflammatory reaction and atherogenic effect was significantly attenuated in endothelial cell with siRNA-NR4A3, native endothelial cells and macrophages from NR4A3-KO mice and in NR4A3-KO mice. Co-localization of NR4A3 with CD31 was observed in atherosclerotic plaque from diabetic patients. Moreover, glycated apoA-IV but not apoA-IV induced trans-activation of NR4A3 to the promoter of adhesion molecules (VCAM-1, ICAM-1 and E-selectin). ESI-Q-TOF-MS identified several glycation sites including K78, K189 and K328 in apoA-IV from diabetic patients, but not in controls. Mutated apoA-IV proteins (m-apoA-IV-K78A/K189A/K328A) were made. In vitro glycated m-apoA-IV displayed significantly attenuated activation of NR4A3 in endothelial cells and atherogenesis in apoE-KO mice, as compared with glycated apoA-IV. Conclusion: Glycation of apoA-IV is associated with the severity of coronary artery disease in diabetic patients and glycated apoA-IV protein promotes atherogenesis through nuclear receptor NR4A3 mediation.

Nonenzymatic Glycation of High‐density Lipoprotein Impairs Its Anti‐inflammatory Effects in Innate Immunity

Toll-like receptor 4-mediated hyper-responsiveness of gingival epithelial cells to lipopolysaccharide in high-glucose environments.

Lysine Glycation of Apolipoprotein A-I Impairs Its Anti-Inflammatory Function in Type 2 Diabetes Mellitus.

Dysfunction of Annexin A2 Contributes to Hyperglycaemia-Induced Loss of Human Endothelial Cell Surface Fibrinolytic Activity

Glycation of High-Density Lipoprotein Triggers Oxidative Stress and Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells

Oxidized High-Density Lipoprotein Enhances Inflammatory Activity in Rat Mesangial Cells

Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages.

Serum Amyloid A Enrichment Impairs the Anti-Inflammatory Ability of HDL from Diabetic Nephropathy Patients.

Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism

Diabetes-Invoked High-Density Lipoprotein and Its Association with Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus.

Normal HDL Cholesterol Efflux and Anti-Inflammatory Capacities in Type 2 Diabetes Despite Lipidomic Abnormalities

Glycated Insulin Exacerbates the Cytotoxicity of Human Islet Amyloid Polypeptides: a Vicious Cycle in Type 2 Diabetes

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Effects of diabetic HDL on endothelial cell function.

High-density Lipoprotein of Patients with Type 2 Diabetes Mellitus Upregulates Cyclooxgenase-2 Expression and Prostacyclin I-2 Release in Endothelial Cells: Relationship with HDL-associated Sphingosine-1-phosphate

Glycation of ApoA-IV is Associated With the Severity of Coronary Artery Disease in Diabetic Patients and Glycated ApoA-IV Protein Promotes Atherogenesis Through Nuclear Receptor NR4A3 Mediation

HDL in Diabetic Nephropathy Has Less Effect in Endothelial Repairing Than Diabetes Without Complications.

High glucose up-regulates lipopolysaccharide-stimulated inflammatory cytokine production via c-jun N-terminal kinase in the monocytic cell line THP-1

Fasting Glucose Level Modulates Cell Surface Expression of CD11b and CD66b in Granulocytes and Monocytes of Patients With Type 2 Diabetes

Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity